The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia

Prostate

Volumn 53, Issue 2, 2002, Pages 168-174

  Hayami, Shinsuke ^a   Ushiyama, Tomomi ^a   Kurita, Yutaka ^a   Kageyama, Shinji ^a   Suzuki, Kazuo ^a   Fujita, Kimio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Benign prostatic hyperplasia (BPH); Histology; Presumed circle area ratio (PCAR); Resistive index (RI)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; MALE; ORGAN SIZE; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; RADIODIAGNOSIS; SMOOTH MUSCLE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC;

EID: 0036789221     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10153     Document Type: Article

References (24)

1. Kojima M, Ochiai A, Naya Y, Ukimura O, Watanabe M, Watanabe H: Correlation of presumed circle area ratio with infravesical obstruction in men with lower urinary tract symptoms. Urology 1997;50:548-555.
2. Kojima M, Naya Y, Inoue W, Ukimura O, Watanabe M, Saitho M, Watanabe H: The American urological association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate. J Urol 1997;50:2160-2165.
3. Appell RA, England HR, McGuire EJ. The effect of epidural anesthesia on the urethral closure pressure profile in patients with prostatic enlargement. J Urol 1980;124:410-411.
4. Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986;136:1-4.
5. Vaalasti A, Hervonen A. Autonomic innervation of the human prostate. Invest Urol 1980;17:293-297.
6. Baumgarten HG, Falck B, Holstein AF, Owman C, Owman T. Adrenergic innervation of the human testis, epididymis, ducts deferens and prostate: A fluorescence microscopic and fluorimetric study. Z Zellforsch 1968;90:81-90.
7. Ishigooka M, Hashimoto T, Hayami S, Suzuki Y, Sasagawa I, Nakada T. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia. Prostate 1996;28:385-391.
8. Shapiro E, Hartanto V, Lepor H. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 1992;21:297-307.
9. Watanabe H, Igari D, Tanahashi Y, Harada K, Saitoh M. Transrectal ultrasonotomography of the prostate. J Urol 1975;114:734-739.
10. Hammerer PG, McNeal JE, Stamey TA. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 1995;153:111-114.
11. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999;53:581-589.
12. Cornud F, Belin X, Piron D, Chre'tien Y, Flam T, Casanova JM, He'le'non O, Me'jean A, Thiounn N, Moreau JF. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997;49:709-715.
13. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiol 1993;186:509-513.
14. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler sonography. Radiol 1994;190:853-856.
15. Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O. Preliminary results of Power Doppler imaging in benign prostatic hyperplasia. Ultrasound in Med Biol 1997;23:1305-1309.
16. Bartsch G, Muller HR, Obertholzer M, Rohr HP. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979;122:487-491.
17. Marks LS, Treiger B, Dorey FJ, Fu YS, DeKernion JB. Morphometry of the prostate. I. Distribution of tissue components in hyperplastic glands. Urology 1994;44:486-492.
18. Siegel YI, Zaidel L, Hammel I, Korczak D. Morphometrical evaluation of benign prostatic hyperplasia. Eur Urol 1990;8:71- 73.
19. Marks LS, Partin AW, Dorey FJ, Gormley GJ, Epstein JI, Garris JB, Macairan ML, Shery ED, Santos PB, Stoner E, deKernion JB. Long-term effects of finasteride on prostate tissue composition. Urology 1999;53:574-580.
20. Robert M, Costa P, Bressolle F, Mottet N, Navratil H. Percent area density of epithelial and mesenchymal components in benign prostatic hyperplasia: Comparison of results between single biopsy, multiple biopsies and multiple tissue specimens. Br J Urol 1995;75:317-324.
21. Kurita Y, Masuda H, Suzuki K, Fujita K, Kawabe K. Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy. Br J Urol 1997;80:78-83.
22. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998;51:595-600.
23. Nelson TR, Pretorius DH. The Doppler signal: where dose it come from and what dose it mean? AJR 1988;151:439-447.
24. Halpern EJ, Deane CR, Needleman L, Merton DA, East SA. Normal renal artery spectral Doppler waveform: a closer look. Radiol 1995;196:612-613.